1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Tacrolimus immediate-release formulation: new trials by email Literature Review of Tacrolimus immediate-release formulation trials Research Report on Tacrolimus immediate-release formulation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients Tacrolimus immediate-release formulation, Tacrolimus prolonged-release formulation, Induction therapy - Kidney Transplant | Phase 4 | Completed | Astellas Pharma China, Inc. | 284 | 2018-10-21 | 2024-10-31 |
Astellas Pharma China, Inc. (1)
China (1)